4//SEC Filing
Henig Noreen 4
Accession 0001209191-20-026796
CIK 0001645666other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:36 PM ET
Size
5.6 KB
Accession
0001209191-20-026796
Insider Transaction Report
Form 4
Henig Noreen
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2020-05-01+300,000→ 300,000 totalExercise: $4.56Exp: 2030-04-30→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on May 1, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such vesting date.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0001810995
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:36 PM ET
- Size
- 5.6 KB